J&J reported $49.04B in Debt for its fiscal quarter ending in June of 2026.





Debt Change Date
AbbVie USD 70.82B 2.04B Jun/2026
Abbott USD 34.05B 20.19B Mar/2026
Amgen USD 57.3B 19M Jun/2026
AstraZeneca USD 32.24B 1.68B Jun/2026
Baxter International USD 9.67B 20M Jun/2026
Bayer EUR 36.45B 2.93B Dec/2025
Becton, Dickinson and Co. USD 16.81B 471M Jun/2026
Biogen USD 7.69B 398.3M Sep/2026
Boston Scientific USD 12.62B 1.6B Jun/2026
Bristol-Myers Squibb USD 42.88B 2.18B Sep/2026
CONMED USD 834.25M 26.62M Jun/2026
Cooper Companies USD 2.46B 39.5M Mar/2026
Dexcom USD 1.24B 154.7M Sep/2026
Edwards Lifesciences USD 598.8M 105.6M Sep/2026
Eli Lilly USD 54.91B 11.54B Jun/2026
Gilead Sciences USD 26.25B 4.07B Jun/2026
GlaxoSmithKline GBP 18.24B 818M Jun/2026
Globus Medical USD 111.19M 4.03M Jun/2026
Insulet USD 962.1M 13.7M Sep/2026
Integra LifeSciences USD 2.05B 9.43M Jun/2026
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 49.04B 5.95B Jun/2026
Medtronic USD 28.15B 192M Jun/2026
Merck USD 53.91B 4.79B Jun/2026
Merit Medical Systems USD 820.12M 1.44M Jun/2026
Novartis USD 49.01B 2.02B Jun/2026
Pfizer USD 62.67B 523M Sep/2026
Regeneron Pharmaceuticals USD 2.71B 400K Jun/2026
Roche Holding CHF 33.03B 1.41B Jun/2025
Sanofi EUR 23.58B 3.56B Jun/2026
Stryker USD 14.18B 16M Sep/2026
Tandem Diabetes Care USD 603.39M 811K Sep/2026
Teva Pharmaceutical Industries USD 16.98B 110M Sep/2026
Vertex Pharmaceuticals USD 6.48B 4.5B Sep/2026
Zimmer Biomet Holdings USD 7.5B 25.2M Sep/2026
Zoetis USD 9.24B 0 Jun/2026